New Players on the Block
Please join us for our innovative New Players session where we have invited speakers to present on new products, ideas, investigatory agents and technologies in neurology that are currently in development or have recently been established, for which new and important data has been accumulating.
New Players in MS
Friday, March 24, 2017
16:05-16:20 MS initiative- Merck Serono and Novartis
MS Ready to Work Initiative
Why and how should health care professionals hold conversations with people living with MS regarding work?
Speaker: Antonella Cardone
16:30-16:40 MIDI551: Olaf Stuve, USA
16:40-16:50 Daclizumab: Ron Milo, Israel
16:50-17:00 Deep rTMS study in MS fatigue: Friedmann Paul, Germany
New Players and New Ideas
Saturday, March 25, 2017
18:30-18:40 Modifying the effect of progress Parkinson's disease (PD) daily physical activity?
Dmitrii Pokhabov, Russia
18:40-18:50 How dementia in PD begins: vascular or inflammatory process?
Homa Ebrahimi, Iran
18:50-19:00 Is it possible to develop a preclinical diagnosis of PD basing on a search for biomarkers?
Michael Ugryumov, Russia